The Translation team at Francis Crick Institute are working with Cresset Discovery to bring computational chemistry expertise to the Crick

/in , /by

Cambridge, UK – Cresset Discovery, provider of CADD expertise for drug discovery, is collaborating with the Translation team at The Francis Crick Institute as expert computational chemist in residence. Computational chemistry is a powerful method in tool development and drug discovery. It enables chemists to predict the physical properties and biological activity of compounds prior to synthesis […]

Read more →

OpenEye and Gaussian Collaboration Expands Quantum Chemistry Calculations

/in , /by

SANTA FE, N.M., and WALLINGFORD, Conn. – OpenEye Scientific and Gaussian – both of which are leading computational chemistry software companies – today announced that OpenEye’s Orion® molecular design platform now is supporting Gaussian and its electronic-structure modeling software with automated scientific workflows to facilitate more rapid and comprehensive quantum chemistry calculations. The Orion® Gaussian Module will […]

Read more →

PerkinElmer Launches ChemDraw® V21 Software, Empowering Researchers to Rapidly Create Chemically Intelligent Microsoft PowerPoint Reports

/in /by

Ability to import 3D molecular models with one click accelerates information sharing, collaboration and decision making WALTHAM, Mass. – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced V21 of its ChemDraw® software featuring the ability to import, animate and share 3D chemical structures natively in the Microsoft® PowerPoint® application with one […]

Read more →

Optibrium Adds Augmented Intelligence for Compound Design to its StarDrop Small Molecule Drug Discovery Software

/in , /by

New Inspyra module combines chemists’ expertise with exploratory capabilities of automated compound design Inspyra provides drug designers direct access to powerful AI capabilities, supporting established workflow CAMBRIDGE, UK: Optibrium Ltd, a leading developer of software for drug discovery, today announced the release of the latest version of StarDrop™, its comprehensive software platform for small molecule design, […]

Read more →

Hunt for new IP for the next generation of novel agrochemicals

/in , /by

Globachem renews contract with Cresset Discovery Cambridge, UK – Cresset Discovery, provider of contract consulting for early phase discovery, has been appointed by Globachem, who specialize in developing and marketing high quality crop protection products, to upskill their in-house team and assist them in developing the next generation of novel agrochemicals. Agrochemicals, which include pesticides and fertilizers, facilitate higher yields […]

Read more →

New year, New Beginning: Chemaxon announces new CEO, Richard Jones

/in , /by

Chemaxon, a leader in cheminformatics software development for life science research, announced the appointment of Richard Jones as Chief Executive Officer (CEO). Richard follows owner Ferenc (Csizi) Csizmadia in the position. “Chemaxon has a great reputation globally. Following on from my work in Lab of the Future, I am excited about the opportunity to take […]

Read more →

DISCNGINE PARTNERS UP WITH CHEMAXON TO ENHANCE ITS 3DECISION® PLATFORM FOR INNOVATIVE STRUCTURE-DRIVEN DRUG DISCOVERY

/in , , /by

Discngine, a research and lab informatics software and services company, announces a strategic partnership with ChemAxon, a leading cheminformatics and bioinformatics company. By joining forces, the partners expect to streamline pharma and biotech research involving complex biomolecular structural data. Paris —Discngine’s 3decision platform stores, categorizes and analyzes protein-ligand structural data in a centralized knowledge base. Its fundamental value […]

Read more →

About LUMICKS LUMICKS is a leading life science tools company that develops equipment for Dynamic Single-Molecule and Cell Avidity analysis, two rapidly emerging areas in biology research and immuno-oncology. LUMICKS’ tools allow researchers to build the crucial and as yet unfinished bridge between structure and function at both a molecular and a cellular level. This is achieved by applying and measuring forces around biological interactions, enabling the detailed real-time analysis of underlying biological mechanisms. LUMICKS’ C-Trap® Optical Tweezers – Fluorescence & Label-free Microscopy, allows scientists to analyze complex biological processes in real-time. Similarly, the z-Movi® Cell Avidity Analyzer enables the measurement and selection of immune cells based on their real-time interactions with target cells.

/in , /by

Professor Richard Bourne to head up DeepMatter’s new Scientific Advisory Board DeepMatter Group Plc (AIM: DMTR, “DeepMatter”, the “Group”), the international digital chemistry data company, has created a new Scientific Advisory Board (“SAB”) to be led by Professor Richard Bourne, who was recently promoted to Professor at the University of Leeds and appointed Research Chair […]

Read more →

DeepMatter collaborates with Dr. Reddy’s for its DigitalGlassware® platform

/in , /by

DeepMatter Group Plc (AIM: DMTR, “DeepMatter”, the “Group”), the international digital chemistry data company, has signed a contract with Dr. Reddy’s Laboratories Limited (“Dr. Reddy’s”), based in Hyderabad, India, for its DigitalGlassware® platform. DeepMatter will provide its DigitalGlassware® platform to Dr Reddy’s process development team who are looking to the development and scale up of chemistry procedures to […]

Read more →

Optibrium appoints Professor Andy Black as non-executive Chair

/in , /by

Appointment brings extensive pharmaceutical services and Board experience to drive commercial growth and development of new products to improve speed, efficiency, and productivity of drug discovery CAMBRIDGE, UK: Optibrium™, a developer of software for drug discovery, today announced the appointment of Professor Andy Black as non-executive Chair of its Board of Directors. Following the company’s recent […]

Read more →